ICPerMed Conference 2020
15 October 2020
-
16 October 2020
The second ICPerMed Conference will take place from 15-16 October 2020 at the Maison de la Chimie in Paris, France.
The latest news and events from ECRIN and its partners
Events
Upcoming
International Clinical Trials Day (ICTD) 2021
27 May 2021
-
27 May 2021
Berlin, Germany
ECRIN's celebration of International Clinical Trials Day (ICTD) will be held on May 27th, 2021 in Berlin (Langenbeck-Virchow-Haus Berlin, Luisenstraße 58/59, 10117 Berlin, Germany). The topic will be (patient-)recruitment in clinical trials. More details to come!
Past
Partner Event: EFGCP Annual Conference 2019 Making Clinical Research an Element of Better Healthcare
19 February 2019
-
20 February 2019
Brussels, Belgium
The EFGCP Annual Conference 2019 focuses on achieving better integration of clinical research in healthcare.
HNN 2.0 Webinar on 'Health Research Infrastructures
22 January 2019
-
22 January 2019
Virtual
HEALTH NCP-Net 2.0 is jointly organising (with BBMRI-ERIC, EATRIS-ERIC, ECRIN and ELIXIR) a webinar to learn about the aims and activities of these research infrastructures (RIs) and how to involve and benefit from them within a Horizon 2020 project.
The second part will be a Q&A session.
Presenters:
Partner Workshop: Science and Society EU Research Infrastructures: tackling societal challenges
14 January 2019
-
15 January 2019
Milan, Italy
Research and innovation lie at the heart of Europe’s economic strategy and make a critical contribution to the development of its society and cultures.
The aim of this workshop is to explore ways in which the return on investment in research can be assessed and evaluated. The workshop will also address the question of the future of RIs, the conditions of their success and the effectiveness of their dialogue with society.
Keystone Symposium About Rare Diseases
11 November 2018
-
14 November 2018
The inaugural Keystone Symposium About Rare Diseases will take place at the Vienna BioCenter from 11 to 14 November 2018.
The conference will examine the current and future bottlenecks to gene discovery, disease modeling, and therapeutic approaches for the estimated 7,000 known rare diseases, and suggest strategies to accelerate progress in this regard.